WTC
ANRO icon

WhitTier Trust Company’s Alto Neuroscience ANRO Stock Holding History

WhitTier Trust Company’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$55.9K Hold
2,482
– – ﹤0.01% 703
2025
Q4 		$37.4K Hold
2,482
– – ﹤0.01% 764
2025
Q3 		$17.1K Hold
2,482
– – ﹤0.01% 931
2025
Q2 		$5.46K Hold
2,482
– – ﹤0.01% 1199
2025
Q1 		$5.34K Hold
2,482
– – ﹤0.01% 1172
2024
Q4 		$10.5K Buy
+2,482
New +$15.5K ﹤0.01% 1058

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

WhitTier Trust Company's ANRO Position: Q1 2026 in Review

WhitTier Trust Company held its Alto Neuroscience (ANRO) position steady in Q1 2026 at 2,482 shares worth $55.9K. The position accounts for ﹤0.01% of the portfolio, ranked #703.

WhitTier Trust Company first reported a position in ANRO in Q4 2024 and has held it in 6 quarters since. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • WhitTier Trust Company held 2,482 shares of Alto Neuroscience worth $55.9K as of Q1 2026.
  • WhitTier Trust Company left its Alto Neuroscience share count unchanged in Q1 2026.
  • Alto Neuroscience made up ﹤0.01% of WhitTier Trust Company's portfolio in Q1 2026, its #703 holding.
  • WhitTier Trust Company first reported a position in Alto Neuroscience in Q4 2024 and has held it in 6 quarters since.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on WhitTier Trust Company's 13F filing for Q1 2026, filed 28 Apr 2026.